Prelude Therapeutics (PRLD) Profit After Tax Growth (3y) (2022 - 2026)
Prelude Therapeutics (PRLD) Profit After Tax Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
27.91% |
| Date | Value |
|---|
| Mar 31, 2026 |
27.91% |
| Dec 31, 2025 |
16.86% |
| Sep 30, 2025 |
13.00% |
| Jun 30, 2025 |
-4.49% |
| Mar 31, 2025 |
-2.88% |
| Dec 31, 2024 |
4.36% |
| Sep 30, 2024 |
-1.69% |
| Jun 30, 2024 |
-8.95% |
| Mar 31, 2024 |
-13.85% |
| Dec 31, 2023 |
-19.77% |
| Sep 30, 2023 |
-22.23% |
| Jun 30, 2023 |
-38.69% |
| Mar 31, 2023 |
-42.84% |
| Dec 31, 2022 |
-41.83% |
| Sep 30, 2022 |
-64.47% |
